Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Teladoc Health Stock Is Soaring Today

By Brian Feroldi - Updated Oct 31, 2019 at 12:58PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares jump in response to better-than-expected earnings and bullish guidance.

What happened

Shares of Teladoc (TDOC -3.14%), a growth company focused on virtual healthcare services, rose as much as 14% on Thursday after the company reported third-quarter earnings. Shares were up about 12% as of 1:33 p.m. EDT today. 

So what

Here's are the key numbers from the third quarter:

  • Revenue jumped 24% to $138 million. That exceeded the $136.5 million that Wall Street was expecting.
  • Total visits increased 45% to 928,000.
  • U.S. paid membership grew 55% to 35 million.
  • Gross margin contracted by 20 basis points to 69%.
  • Adjusted EBITDA rose 42% to $9 million.
  • The net loss dropped 13% to $20.3 million, or $0.28 per share. That was much lower than the $0.39 net loss per share that analysts were expecting. 
Hands on a laptop video chatting with a doctor

Image source: Getty Images.

CEO Jason Gorevic said, "The third quarter marked a continuation of Teladoc Health's very strong momentum from the first half of the year, as we delivered at the high end of our growth expectations and made progress on our path to profitability."

Traders bid up the share price in response to the upbeat quarterly results.

Now what

Here's the guidance for the fourth quarter:

  • Total revenue is expected to land between $149 million and $153 million.
  • Adjusted EBITDA is expected to be in the range of $11.5 million to $15.5 million.
  • Net loss per share is expected to land between $0.31 and $0.37.

For context, Wall Street was expecting $148 million in revenue and a net loss of $0.33 per share.

Guidance was also updated for the full-year 2019:

  • Total revenue is expected to land between $546 million and $550 million.
  • Adjusted EBITDA is projected to be in the range of $28 million to $32 million.
  • Net loss per share is expected between $1.43 and $1.49.

These numbers compare favorably with the current consensus estimates in the analyst community of $543.6 million in total revenue and a net loss per share of $1.55 for the full year.

Brian Feroldi has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$34.82 (-3.14%) $-1.13

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.